Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapy

Fig. 3

Dynamic measures of ANC and WBC in phase 1b (a-d), phase 2b (e-f), and phase 2 (g-h). The delivery pattern of rHSA/G-CSF in randomized trials were shown on the top of the corresponding curves, while the ranges of grade 4, grade 3, and normalization were demonstrated in accordance with the corresponding values

Back to article page